Rene E. Toes

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 307 publications

Selective Elimination of Autoreactive B Cells Using Multivalent Polyisocyanopeptide-Based Antigen-Toxin Conjugates.

Selective Elimination of Autoreactive B Cells Using Multivalent Polyisocyanopeptide-Based Antigen-Toxin Conjugates.

Journal: Biomacromolecules

Published: June 22, 2026

Interleukin-6 stimulates platelet 12-lipoxygenase to drive coagulation in inflammatory arthritis.

Interleukin-6 stimulates platelet 12-lipoxygenase to drive coagulation in inflammatory arthritis.

Journal: Journal of lipid research

Published: May 29, 2026

Comprehensive Lipidomic Profiling Reveals Distinct Metabolic Remodeling during Differentiation of Human Monocyte-Derived Macrophages.

Comprehensive Lipidomic Profiling Reveals Distinct Metabolic Remodeling during Differentiation of Human Monocyte-Derived Macrophages.

Journal: Journal of proteome research

Published: May 28, 2026

CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial.

CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial.

Journal: Nature medicine

Published: March 20, 2026

Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell activating factor levels and a B cell subset-wide reduction of BAFF-receptor expression in SSc.

Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell activating factor levels and a B cell subset-wide reduction of BAFF-receptor expression in SSc.

Journal: Rheumatology (Oxford, England)

Published: February 23, 2026

Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell-activating factor levels and a B cell subset-wide reduction of BAFF receptor expression in systemic sclerosis.

Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell-activating factor levels and a B cell subset-wide reduction of BAFF receptor expression in systemic sclerosis.

Journal: Rheumatology (Oxford, England)

Published: February 23, 2026

Targeting autoreactive B cells in rheumatoid arthritis through MHC class I-presented BCR-derived neo-epitopes.

Targeting autoreactive B cells in rheumatoid arthritis through MHC class I-presented BCR-derived neo-epitopes.

Journal: Journal of autoimmunity

Published: February 20, 2026

Dual dynamics of persistence and recruitment characterise the ACPA-expressing B cell response in rheumatoid arthritis.

Dual dynamics of persistence and recruitment characterise the ACPA-expressing B cell response in rheumatoid arthritis.

Journal: Annals of the rheumatic diseases

Published: January 21, 2026

Symmetrical dimethylarginine as the central antigenic determinant of anti-Smith autoantibodies in systemic lupus erythematosus.

Symmetrical dimethylarginine as the central antigenic determinant of anti-Smith autoantibodies in systemic lupus erythematosus.

Journal: Annals of the rheumatic diseases

Published: December 22, 2025

The Role of IgM Anti-acetylated Protein Antibodies and B Cells in the Origin of Antimodified Protein Autoimmunity in Rheumatoid Arthritis.

The Role of IgM Anti-acetylated Protein Antibodies and B Cells in the Origin of Antimodified Protein Autoimmunity in Rheumatoid Arthritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: December 09, 2025

The role of IgM anti-acetylated protein antibodies and B cells in the origin of anti-modified protein autoimmunity in rheumatoid arthritis.

The role of IgM anti-acetylated protein antibodies and B cells in the origin of anti-modified protein autoimmunity in rheumatoid arthritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: December 09, 2025

Reply to the correspondence on 'Development of bispecific antibodies that allow targeted local complement inhibition on rheumatoid arthritis related antigens'.

Reply to the correspondence on 'Development of bispecific antibodies that allow targeted local complement inhibition on rheumatoid arthritis related antigens'.

Journal: Annals of the rheumatic diseases

Published: November 13, 2025

Showing 1-12 of 307

Last Updated: 09/26/2026